Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Anura

ABSTRACT: Targeted AMP amplification in Anura

PROVIDER: PRJNA415374 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6202870.fastq.gz	Fastqsanger.gz
	SRR6202861.fastq.gz	Fastqsanger.gz
	SRR6202871.fastq.gz	Fastqsanger.gz
	SRR6202862.fastq.gz	Fastqsanger.gz
	SRR6202872.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 14

Similar Datasets

Anura sp.

Project description:Anura Targeted Locus (Loci)

| PRJNA194127 | ENA

Anura

Project description:Anura Transcriptome or Gene expression

| PRJNA271360 | ENA

Anura

Project description:Anura Skin bacteria cultures Raw sequence reads

| PRJNA594203 | ENA

Anura

Project description:Class: Amphibia, Order: Anura. raw sequence reads

| PRJNA291277 | ENA

Anura

Project description:Exploring the impact of phylogenetic relationships of the living lineages of amphibians with transcriptomes

| PRJNA430346 | ENA

Anura

Project description:Is MHC in Japanese frogs important for resistance to the deadly chytrid fungus?

| PRJDB11134 | ENA

Anura

Project description:FrogCap: A modular sequence capture probe set for phylogenomics and population genetics for all frogs, assessed across multiple phylogenetic scales

| PRJNA633673 | ENA

Controlled library preparation of STR-bearing minigenes at three amplification time-points

Project description:We have designed a method for direct measurement of in vitro noise. Using a synthetic STR sequencing library, we have measured the stutter patterns at various levels of PCR amplification during targeted amplification and library preparation processes

2019-01-26 | E-MTAB-7602 | biostudies-arrayexpress

Affymetrix SNP array data for mammary tumors that recurred after inactivation of the oncogenic PIK3CA-H1047R

Project description:Gain-of-function mutation of PIK3CA represents one of the most common oncogenic events in human malignancy, making PI3K an attractive target for cancer therapy. Despite the great promise of targeted therapy, drug resistance is likely to develop, causing treatment failure. To elucidate resistance mechanisms to PI3K-targeted therapy, we constructed a mouse model of breast cancer conditionally expressing PIK3CA-H1047R. Surprisingly, the majority of mammary tumors induced by PIK3CA-H1047R expression recurred following PIK3CA-H1047R inactivation. Genomic analyses of recurrent tumors revealed multiple lesions, including spontaneous focal amplification of c-Met or c-Myc. While amplification of c-Met allowed tumor survival dependent on activation of endogenous PI3K, tumors with amplification of c-Myc become independent of the PI3K pathway. Functional analyses further demonstrated that c-Myc contributed to tumors’ independence of oncogene and resistance to PI3K inhibition. Together, our data suggest that MYC elevation in tumors may be a potential mechanism conferring resistance to current PI3K-targeted therapies.

2011-08-02 | GSE27691 | GEO

Project description:Eukaryota Metazoa Chordata Craniata Vertebrata Euteleostomi Amphibia Batrachia Anura Neobatrachia Hyloidea Targeted loci

| PRJNA601170 | ENA